SKYE
Skye Bioscience, Inc.
1.80$
+5.3%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -23.5% | +694.2% | -8.0% | -6.6% | -10.8% | -11.0% | -19.5% | -20.8% | -31.5% | -31.4% | -43.2% | |
| – | -23.8% | +711.7% | -8.0% | -8.3% | -11.3% | -11.0% | -19.7% | -21.1% | -32.1% | -31.5% | -41.0% | |
| – | -75.5% | +6,533.2% | -11.1% | -9.1% | +1.5% | -32.1% | -48.6% | -22.6% | -68.1% | +38.5% | -1.0% | |
| – | -75.5% | +6,533.2% | -11.1% | -9.1% | +1.5% | -13.4% | -18.0% | -27.3% | -27.1% | -33.5% | -41.2% | |
| – | -81.4% | -5.7% | -100.0% | +18,290.0% | +37.7% | +26.1% | +111.1% | +24.3% | -37.5% | -9.1% | – | |
| – | -108.1% | – | +17.1% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.2% | +13.4% | -9.4% | -60.3% | -19.5% | +20.2% | +53.1% | +0.0% | -2.3% | +25.5% | +10.8% | |
| – | +1.3% | +13.7% | -9.4% | -60.7% | -22.9% | +22.6% | +56.3% | +0.7% | -1.9% | +26.8% | +10.8% | |
| – | +4.9% | +5.4% | +5.4% | -98.3% | +120.0% | +3.4% | +3.4% | +3.4% | -5.9% | +64.2% | -88.5% | |
| – | -41.4% | +14.5% | -1.4% | -27.7% | -27.0% | +201.1% | +88.0% | -12.3% | -28.0% | +93.6% | +8.7% | |
| – | -225.8% | – | -7.7% | +4.1% | -10.1% | -13.1% | -26.3% | -24.8% | -39.0% | -55.0% | -105.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -99.8% | +126.7% | +38.1% | +0.4% | +3.0% | -0.8% | +0.0% | +0.0% | 0.0% | +0.0% | +0.0% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.